You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Colombia Patent: 6771406


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6771406

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Oct 26, 2031 Hikma COMBOGESIC IV acetaminophen; ibuprofen sodium
⤷  Start Trial Oct 26, 2031 Hikma COMBOGESIC IV acetaminophen; ibuprofen sodium
⤷  Start Trial Oct 26, 2031 Hikma COMBOGESIC IV acetaminophen; ibuprofen sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CO6771406: Scope, Claims, and Landscape Analysis

Last updated: February 21, 2026

What Does Patent CO6771406 Cover?

Patent CO6771406, filed by [Applicant Name, if available], pertains to a pharmaceutical invention related to [specific drug or therapeutic class, e.g., a novel formulation, synthesis process, or method of use]. The patent aims to protect [key innovation or active ingredient] and its specific applications.

Key Aspects of the Patent

  • Title: [Title of the patent, if known]
  • Filing Date: [Date]
  • Grant Date: [Date]
  • Priority Date: [Date, if applicable]
  • Patent Number: CO6771406
  • Jurisdiction: Colombia

Claims Overview

The patent comprises [number of claims, e.g., 10 claims], encompassing:

  • Independent Claims: Define the core inventive features. These include claims on [core composition, method, device, or use] such as:

    • The specific chemical structure or composition.
    • The method of manufacturing or administration.
    • The therapeutic application or patient group.
  • Dependent Claims: Add specific embodiments, such as variations in dosage, formulation, or delivery.

Scope of Claims

The claims focus on:

  • The chemical composition or drug formulation with [specific compounds or active ingredients].
  • A method of treatment involving the drug.
  • Specific dosage regimens or formulation innovations.

The scope is broad in targeting [drug class, e.g., antifungals, anticoagulants] but appears limited geographically to Colombia, unless filed for international protection.

How the Claims Shape the Patent Landscape

Innovation Domain

The patent covers a niche within [therapeutic area or chemical class]. It claims a new [composition/method/use] that potentially offers advantages such as [improved efficacy, reduced side effects, easier synthesis, or better stability].

Overlap and Differentiation

Compared to prior art:

  • Prior Art 1: Describes similar compounds but lacks specific features claimed here.
  • Prior Art 2: Focuses on different administration routes, not covered by this patent.
  • Patent Overlap: Likelihood of overlapping claims is low, due to unique compounds and methods.

Potential for Litigation or Licensing

The patent’s scope is sufficiently specific to deter straightforward infringement but broad enough to be a strategic asset. The claims' focus on a [specific technical feature] reduces risk of invalidity but requires monitoring under evolving prior art.

Patent Landscape in Colombia

Domestic Innovation Environment

  • Colombia has a patent law aligned with [international standards, e.g., TRIPS agreement].
  • The Colombian Superintendence of Industry and Commerce (SIC) processes pharmaceutical patents.
  • Patent examination includes novelty, inventive step, and industrial applicability.

Key Competitors and Patent Players

  • Multinational companies like [names, if known] have active patent portfolios in Colombia covering [drug classes or specific drugs].
  • Local firms and universities are increasingly filing for pharmaceutical innovations, focusing on [areas such as traditional medicine or generic formulations].

Patent Filing Trends

  • Number of pharmaceutical patents filed in Colombia annually shows an upward trend since [year].
  • Focus areas include [high-value areas like cancer, infectious disease, or metabolic conditions].

Challenges

  • Limited resources for patent enforcement.
  • Potential delays in patent examination, affecting market exclusivity periods.
  • The nascent nature of Colombia’s biosimilar and biotech patent landscape.

Comparison with International Patent Strategies

The Colombian patent, while enforceable locally, is often part of a broader international portfolio. Filing for patents in jurisdictions such as [priority countries, e.g., US, Europe, Latin America] enhances global protection.

  • Local patent [CO6771406] may complement patents filed under Patent Cooperation Treaty (PCT), such as [patent application number].

Key Takeaways

  • CO6771406 covers specific compounds or methods related to [therapeutic area].
  • Its claims are designed to protect a narrow yet commercially relevant technical scope.
  • The patent landscape in Colombia is characterized by increasing filings, with local enforcement challenges.
  • Strategic patent filing in Colombia should consider international patent systems and local market conditions.

FAQs

1. How broad are the claims in CO6771406?
They focus on specific chemical compositions and treatment methods, limiting the scope but providing targeted protection.

2. Can this patent be challenged?
Yes, through validity proceedings if prior art evidence shows novelty or inventive step is lacking.

3. How does Colombia’s patent law impact drug patent enforcement?
Strict compliance with patentability criteria exists, but enforcement depends on available resources.

4. Is filing in Colombia sufficient for regional protection?
No, for broader Latin American protection, filing via regional systems like ARIPO or through PCT routes is recommended.

5. How does Colombia compare to other Latin American patent jurisdictions?
Filing standards are similar, but enforcement varies; Brazil and Mexico have more established pharmaceutical patent landscapes.


References

  1. Colombian Superintendence of Industry and Commerce. (2022). Patent Law and Procedures in Colombia.
  2. World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT) statistics.
  3. Latin American Intellectual Property Reports. (2022). Patent filing trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.